Rezolute RZLT
NASDAQ RZLT
$4.58 +0.04 (+0.88%)
As of: Sep 4, 2026 · 3:59 PM EDT

Rezolute (RZLT) Free Cash Flow (2010 - 2026)

Rezolute (RZLT) posted Free Cash Flow of -$13.7 million for Q1 2026, up 32.9% sequentially from -$20.4 million in Q4 2025, and up 21.33% YoY from -$11.3 million in Q1 2025.

Analysis

Rezolute (RZLT) Free Cash Flow (2010 - 2026) Analysis & Trends

Rezolute has reported Free Cash Flow for 17 years, with the latest figure at -$13.7 million in Q1 2026.

  • Quarterly Free Cash Flow rose 21.33% year-over-year to -$13.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$73.5 million (down 12.05% YoY) and the FY2025 annual result came in at -$69.1 million, down 20.45% from the prior year.
  • Free Cash Flow advanced to -$13.7 million in Q1 2026 per RZLT's latest filing, from -$20.4 million in the prior quarter.
  • Over five years, Free Cash Flow peaked at -$7.6 million in Q4 2022 and troughed at -$22.0 million in Q2 2025.
  • A 5-year average of -$14.6 million and a median of -$14.0 million in 2022 frame the typical range for Free Cash Flow.
  • The sharpest annual moves came in 2022 and 2026: Free Cash Flow tumbled 158.81% in 2022, then rose 21.33% in 2026.
  • Over 5 years, Free Cash Flow stood at -$7.6 million in 2022, then slumped by 71.86% to -$13.0 million in 2023, then declined by 4.96% to -$13.7 million in 2024, then plunged by 49.28% to -$20.4 million in 2025, then soared by 32.9% to -$13.7 million in 2026.
  • According to Business Quant data, Free Cash Flow over the past three periods registered -$13.7 million, -$20.4 million, and -$17.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Free Cash Flow (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 1.01 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 572.80 Mn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -563.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - -389.61 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 437.80 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 292.04 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 477.44 Mn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn -95.09 Mn
10 Rezolute 477.02 Mn 477.02 Mn - -13.70 Mn
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 -13.70 Mn
Dec 31, 2025 -20.37 Mn
Sep 30, 2025 -17.43 Mn
Jun 30, 2025 -22.02 Mn
Mar 31, 2025 -17.40 Mn
Dec 31, 2024 -13.67 Mn
Sep 30, 2024 -16.01 Mn
Jun 30, 2024 -18.52 Mn
Mar 31, 2024 -15.24 Mn
Dec 31, 2023 -13.02 Mn
Sep 30, 2023 -10.59 Mn
Jun 30, 2023 -11.35 Mn
Mar 31, 2023 -18.05 Mn
Dec 31, 2022 -7.58 Mn
Sep 30, 2022 -7.66 Mn
Jun 30, 2022 -12.11 Mn
Mar 31, 2022 -13.97 Mn
Dec 31, 2021 -7.20 Mn
Sep 30, 2021 -6.34 Mn
Jun 30, 2021 -5.23 Mn